• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器械治疗相关并发症:种类、发生率及处理。

Complications in Device Therapy: Spectrum, Prevalence, and Management.

机构信息

Liverpool Heart and Chest Hospital NHS Foundation Trust, Thomas Drive, Liverpool, L14 3PE, UK.

Wirral University Teaching Hospital NHS Foundation Trust, Arrowe Park Road, Upton, Wirral, CH49 5PE, UK.

出版信息

Curr Heart Fail Rep. 2022 Oct;19(5):316-324. doi: 10.1007/s11897-022-00563-0. Epub 2022 Aug 6.

DOI:10.1007/s11897-022-00563-0
PMID:35932445
Abstract

PURPOSE OF REVIEW

Cardiac implantable electronic device implant numbers are continually increasing due to the expanding indications and ageing population. This review explores the complications associated with device therapy and discusses ways to minimise and manage such complications.

RECENT FINDINGS

Complications related to device therapy contribute to mortality and morbidity. Recent publications have detailed clear guidelines for appropriate cardiac device selection, as well as consensus documents discussing care quality and optimal implantation techniques. There have also been advances in device technologies that may offer alternative options to patients at high risk of/or already having encountered a complication. Adherence to guidelines, appropriate training, and selection of device, in addition to good surgical technique are key in reducing the burden of complications and improving acceptability of device therapy.

摘要

目的综述

由于适应证的不断扩大和人口老龄化,心脏植入式电子设备的植入数量不断增加。本综述探讨了与设备治疗相关的并发症,并讨论了如何尽量减少和管理这些并发症。

最新发现

与设备治疗相关的并发症导致死亡率和发病率增加。最近的出版物详细说明了适当的心脏设备选择的明确指南,以及讨论护理质量和最佳植入技术的共识文件。设备技术也取得了进展,为高风险/或已经遇到并发症的患者提供了替代选择。此外,遵循指南、适当的培训、设备的选择以及良好的手术技术是减少并发症负担和提高设备治疗可接受性的关键。

相似文献

1
Complications in Device Therapy: Spectrum, Prevalence, and Management.器械治疗相关并发症:种类、发生率及处理。
Curr Heart Fail Rep. 2022 Oct;19(5):316-324. doi: 10.1007/s11897-022-00563-0. Epub 2022 Aug 6.
2
Cardiovascular implantable electronic device lead extraction: evidence, techniques, results, and future directions.心血管植入式电子设备导线拔除:证据、技术、结果及未来方向。
Curr Opin Cardiol. 2016 Jan;31(1):23-8. doi: 10.1097/HCO.0000000000000247.
3
Considerations for cardiac device lead extraction.心脏装置导线拔除的注意事项。
Nat Rev Cardiol. 2016 Apr;13(4):221-9. doi: 10.1038/nrcardio.2015.207. Epub 2016 Jan 29.
4
[Device associated complications].[与设备相关的并发症]
Herzschrittmacherther Elektrophysiol. 2013 Sep;24(3):139-40. doi: 10.1007/s00399-013-0280-8.
5
Extraction of implantable cardiac electronic devices.心脏植入式电子设备的取出。
Curr Cardiol Rep. 2011 Oct;13(5):407-14. doi: 10.1007/s11886-011-0198-x.
6
Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.需要手术修正的植入式设备并发症的发生率、原因及其对患者预后的影响:来自意大利两个中心的大型人群调查。
Europace. 2013 Apr;15(4):531-40. doi: 10.1093/europace/eus337. Epub 2013 Feb 13.
7
[Device related infections. How to identify and how to treat].[与设备相关的感染。如何识别及如何治疗]
Herzschrittmacherther Elektrophysiol. 2013 Sep;24(3):148-51. doi: 10.1007/s00399-013-0286-2.
8
Pacemaker and ICD leads: strategies for long-term management.起搏器和植入式心律转复除颤器导线:长期管理策略
J Interv Card Electrophysiol. 2008 Oct;23(1):59-72. doi: 10.1007/s10840-008-9249-7. Epub 2008 Apr 8.
9
Coronary Sinus Lead Extraction.冠状静脉窦导线拔除术
Heart Fail Clin. 2017 Jan;13(1):105-115. doi: 10.1016/j.hfc.2016.07.009.
10
Percutaneous Lead Extraction in Infection of Cardiac Implantable Electronic Devices: a Systematic Review.心脏植入式电子设备感染中的经皮导线拔除术:一项系统评价。
Braz J Cardiovasc Surg. 2018 Mar-Apr;33(2):194-202. doi: 10.21470/1678-9741-2017-0144.

本文引用的文献

1
Preoperative checklist to reduce the risk of cardiac implantable electronic device infections.术前检查表,降低心脏植入式电子设备感染风险。
Pacing Clin Electrophysiol. 2022 Feb;45(2):262-269. doi: 10.1111/pace.14429. Epub 2022 Jan 13.
2
Computed tomography validated right ventricular mid-septal lead implantation using right ventricular angiography.计算机断层扫描通过右心室血管造影术验证右心室中隔导联植入情况。
J Arrhythm. 2021 Jul 11;37(5):1131-1138. doi: 10.1002/joa3.12591. eCollection 2021 Oct.
3
European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology.
欧洲心脏病学会心脏起搏护理和结局质量指标:由心脏起搏质量指标工作组与欧洲心脏病学会的欧洲心律协会合作制定。
Europace. 2022 Jan 4;24(1):165-172. doi: 10.1093/europace/euab193.
4
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.2021年欧洲心脏病学会心脏起搏与心脏再同步治疗指南。
Eur Heart J. 2021 Sep 14;42(35):3427-3520. doi: 10.1093/eurheartj/ehab364.
5
Subclinical cardiac perforation by cardiac implantable electronic device leads detected by cardiac computed tomography.心脏 CT 检测到心内植入式电子装置导线导致的亚临床性心脏穿孔。
BMC Cardiovasc Disord. 2021 Jul 19;21(1):346. doi: 10.1186/s12872-021-02159-3.
6
Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.心脏植入式电子设备程序引起的血肿的感染后果和抗生素包膜的作用:WRAP-IT 试验分析。
Heart Rhythm. 2021 Dec;18(12):2080-2086. doi: 10.1016/j.hrthm.2021.07.011. Epub 2021 Jul 17.
7
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.2021年欧洲心律协会心房颤动患者使用非维生素K拮抗剂口服抗凝药实用指南。
Europace. 2021 Oct 9;23(10):1612-1676. doi: 10.1093/europace/euab065.
8
EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS).EHRA 专家共识声明及关于传统起搏器和植入式心律转复除颤器最佳植入技术的实用指南:得到了心脏节律学会(HRS)、亚太心脏节律学会(APHRS)和拉丁美洲心脏节律学会(LAHRS)的认可。
Europace. 2021 Jul 18;23(7):983-1008. doi: 10.1093/europace/euaa367.
9
Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trial.低温电灼术降低了二次心脏植入式电子装置手术的不良影响:WRAP-IT 试验的结果。
Heart Rhythm. 2021 Jul;18(7):1142-1150. doi: 10.1016/j.hrthm.2021.03.033. Epub 2021 Mar 27.
10
Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis.皮下与经静脉植入式除颤器:一项更新的荟萃分析。
Heart Rhythm. 2021 Mar;18(3):382-391. doi: 10.1016/j.hrthm.2020.11.013. Epub 2020 Nov 16.